|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Sotalol#Contraindications]] |
| {{Sotalol}}
| |
| {{CMG}}
| |
| | |
| ==Contraindications==
| |
| | |
| Betapace (sotalol hydrochloride) is contraindicated in patients with [[bronchial asthma]], [[sinus bradycardia]] second and third degree [[AV block]], unless a functioning [[pacemaker]] is present, congenital or acquired [[long QT syndrome]]s, [[cardiogenic shock]], uncontrolled [[congestive heart failure]], and previous evidence of [[hypersensitivity]] to Betapace.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BETAPACE (SOTALOL HYDROCHLORIDE) TABLET [BAYER HEALTHCARE PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Antiarrhythmic agents]]
| |
| [[Category:Beta blockers]]
| |
| [[Category:Drugs]]
| |